Middle East & Africa Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Technology, Method, Test Type, Pathogen, and End User

List of Tables

The Middle East & Africa sepsis diagnostics market is expected to grow from US$ 19.20 million in 2021 to US$ 33.35 million by 2028. It is estimated to record a CAGR of 8.2% from 2021 to 2028.

Rising Technological Advancements in Sepsis Diagnosis to Drive Middle East & Africa Sepsis Diagnostics Market Growth During 2021-2028

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the process of sepsis diagnosis, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The adoption of molecular diagnostic technology is increasing due to its several advantages, such as high sensitivity, accuracy, and less turnaround time than other technologies. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. Thus, the rising use of technology such as molecular diagnostics in sepsis diagnosis is a crucial trend followed by emerging key players operating in the Middle East & Africa sepsis diagnostics market .

Middle East & Africa Sepsis Diagnostics Market Overview

The UAE, Saudi Arabia, and South Africa are three major countries in the Middle East & South Africa. The Middle East & Africa sepsis diagnostics market growth is attributed to factors such as growing healthcare expenditure, rising incidence of sepsis diseases, increasing awareness, and the development of innovative diagnostic products by the market players.

Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Sepsis Diagnostics Market Segmentation

The Middle East & Africa sepsis diagnostics market is segmented into product, method, test type, pathogen, end user, and country.

Based on product, the Middle East & Africa sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Middle East & Africa sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Middle East & Africa sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Middle East & Africa sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Middle East & Africa sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Middle East & Africa sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Middle East & Africa sepsis diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2021.

Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the Middle East & Africa sepsis diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa sepsis diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00025662

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Middle East & Africa Sepsis Diagnostics Market - By Product
- 1.3.2 Middle East & Africa Sepsis Diagnostics Market - By Technology
- 1.3.3 Middle East & Africa Sepsis Diagnostics Market - By Method
- 1.3.4 Middle East & Africa Sepsis Diagnostics Market - By Test Type
- 1.3.5 Middle East & Africa Sepsis Diagnostics Market - By Pathogen
- 1.3.6 Middle East & Africa Sepsis Diagnostics Market - By End User
- 1.3.7 Middle East & Africa Sepsis Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Sepsis Diagnostics Market -Market Landscape

4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Experts Opinion

5. Middle East & Africa Sepsis Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
- 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
- 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis

6. Sepsis Diagnostics Market- Middle East & Africa Analysis

6.1 Middle East & Africa Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

7.1 Overview
7.2 Middle East & Africa Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
- 7.3.1 Overview
- 7.3.2 Instruments: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
- 7.4.1 Overview
- 7.4.2 Reagents and Assays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
- 7.5.1 Overview
- 7.5.2 Blood Culture Media: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
- 7.6.1 Overview
- 7.6.2 Software: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

8.1 Overview
8.2 Middle East & Africa Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
- 8.3.1 Overview
- 8.3.2 Molecular Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Polymerase Chain Reaction
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Polymerase Chain Reaction: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Syndromic Panel-Based Testing
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Syndromic Panel-Based Testing: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.4 Microarrays
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Microarrays: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
- 8.4.1 Overview
- 8.4.2 Flow Cytometry: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Real-Time Cell Analysis
  - 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
    - 8.4.3.1.1 Characteristics of TaqMan Assays
  - 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
    - 8.4.3.2.1 Abstract
    - 8.4.3.2.2 Conclusion:
  - 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
  - 8.4.3.4 Sepsis diagnosis by real-time PCR
  - 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
  - 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
- 8.4.4 Real-Time Cell Analysis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
- 8.5.1 Overview
- 8.5.2 Microfluidics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
- 8.6.1 Overview
- 8.6.2 Immunoassay: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
- 8.7.1 Overview
- 8.7.2 Biomarkers: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.7.3 Metabolomics
  - 8.7.3.1 Metabolite Profile in Sepsis
  - 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
  - 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
  - 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
    - 8.7.3.4.1 Genomics
    - 8.7.3.4.2 Proteomics
  - 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
  - 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
  - 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
  - 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
  - 8.7.3.9 Metabolics in Mitochondrial Function
  - 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
- 8.7.4 Metabolomics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
- 8.8.1 Overview
- 8.8.2 Microbiology: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

9.1 Overview
9.2 Middle East & Africa Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
- 9.3.1 Overview
- 9.3.2 Automated Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
- 9.4.1 Overview
- 9.4.2 Conventional Diagnostics: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

10.1 Overview
10.2 Middle East & Africa Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
- 10.3.1 Overview
- 10.3.2 Point-of-Care Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
- 10.4.1 Overview
- 10.4.2 Laboratory Tests: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

11.1 Overview
11.2 Middle East & Africa Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
- 11.3.1 Overview
- 11.3.2 Bacterial Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
- 11.4.1 Overview
- 11.4.2 Fungal Sepsis: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

12.1 Overview
12.2 Middle East & Africa Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
- 12.4.1 Overview
- 12.4.2 Pathology and Reference Laboratories: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
- 12.5.1 Overview
- 12.5.2 Others: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Country Analysis

13.1 Overview
- 13.1.1 Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  - 13.1.1.1 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.1.1 Overview
    - 13.1.1.1.2 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.1.3 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.1.1.4 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.1.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.1.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.1.1.4.3 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.1.1.5 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.1.1.6 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.1.1.7 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.1.1.8 UAE: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.1.1.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.2.1 Overview
    - 13.1.1.2.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.2.3 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.1.2.4 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.1.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.1.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.1.2.4.3 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.1.2.5 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.1.2.6 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.1.2.7 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.1.2.8 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.1.1.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.3.1 Overview
    - 13.1.1.3.2 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.3.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.1.3.4 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.1.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.1.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.1.3.4.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.1.3.5 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.1.3.6 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.1.3.7 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.1.3.8 South Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.1.1.4 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.4.1 Overview
    - 13.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.1.4.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.1.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.1.4.4.3 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.1.4.8 Rest of Middle East & Africa: Middle East & Africa Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

14. Sepsis Diagnostics Market-Industry Landscape

14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
- 14.3.1 Overview
14.4 Inorganic Developments
- 14.4.1 Overview

15. Company Profiles

15.1 Abbott
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 BD
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 Danaher (Beckman Coulter)
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 THERMO FISHER SCIENTIFIC INC.
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 bioMerieux SA
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 T2 Biosystems, Inc.
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments

16. Appendix

16.1 About the Insight Partners
16.2 Glossary of Terms